Total Valuation
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has a market cap or net worth of €3.22B. The enterprise value is €0.00.
Market Cap€3.22B
Enterprise Value€0.00
Share Statistics
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has 200,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding200,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 29.17%.
Return on Equity (ROE)0.30
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)29.17%
Return on Capital Employed (ROCE)0.35
Revenue Per Employee1.26M
Profits Per Employee542.61K
Employee Count3,890
Asset Turnover0.42
Inventory Turnover1.13
Valuation Ratios
The current PE Ratio of Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S is 13.6. Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s PEG ratio is -1.92.
PE Ratio13.6
PS Ratio3.73
PB Ratio2.58
Price to Fair Value2.58
Price to FCF53.57
Price to Operating Cash Flow54.07
PEG Ratio-1.92
Income Statement
In the last 12 months, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had revenue of 4.92B and earned 2.13B in profits. Earnings per share was 2.77.
Revenue4.92B
Gross Profit3.64B
Operating Income2.49B
Pretax Income2.49B
Net Income2.13B
EBITDA2.61B
Earnings Per Share (EPS)2.77
Cash Flow
In the last 12 months, operating cash flow was 540.52M and capital expenditures -110.95M, giving a free cash flow of 429.18M billion.
Operating Cash Flow540.52M
Free Cash Flow429.18M
Free Cash Flow per Share2.15
Dividends & Yields
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.05
52-Week Price Change47.08%
50-Day Moving Average2.40
200-Day Moving Average2.26
Relative Strength Index (RSI)54.01
Average Volume (3m)0.00
Important Dates
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S upcoming earnings date is Aug 15, 2026, Before Open (Confirmed).
Last Earnings DateApr 29, 2026
Next Earnings DateAug 15, 2026
Ex-Dividend Date―
Financial Position
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S as a current ratio of 1.59, with Debt / Equity ratio of 0.77%
Current Ratio1.59
Quick Ratio1.34
Debt to Market Cap<0.01
Net Debt to EBITDA-0.37
Interest Coverage Ratio271.71
Taxes
In the past 12 months, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has paid 376.70M in taxes.
Income Tax376.70M
Effective Tax Rate0.15
Enterprise Valuation
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S EV to EBITDA ratio is 6.66, with an EV/FCF ratio of 50.78.
EV to Sales3.54
EV to EBITDA6.66
EV to Free Cash Flow50.78
EV to Operating Cash Flow37.72
Balance Sheet
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has €1.77B in cash and marketable securities with €53.47M in debt, giving a net cash position of €1.71B billion.
Cash & Marketable Securities€1.77B
Total Debt€53.47M
Net Cash€1.71B
Net Cash Per Share€8.57
Tangible Book Value Per Share€8.82
Margins
Gross margin is 75.02%, with operating margin of 50.63%, and net profit margin of 43.34%.
Gross Margin75.02%
Operating Margin50.63%
Pretax Margin50.59%
Net Profit Margin43.34%
EBITDA Margin53.12%
EBIT Margin50.77%
Analyst Forecast
The average price target for Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―